552
Participants
Start Date
May 19, 2021
Primary Completion Date
December 31, 2022
Study Completion Date
April 22, 2023
Remimazolam
Remimazolam is infused at a rate of 0.25 mg/kg/h from end of anesthesia induction until 15 minutes before the end of surgery.
Placebo
Normal saline is infused at a rate same as in the remimazolam group from end of anesthesia induction until 15 minutes before the end of surgery.
Peking University First Hospital, Beijing
Beijing Hospital of the Ministry of Health, Beijing
Beijing YouAn Hospital, Capital Medical University, Beijing
Fuwai Hospital Chinese Academy of Medical Sciences, Beijing
Tongji Hospital, Tongji Medical College of HUST, Wuhan
Wuhan Puai Hospital, Wuhan
Suzhou Municipal Hospital, Suzhou
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Peking University First Hospital
OTHER